A quantitative pharmacological study of the cholinergic depolarization of hippocampal pyramidal cells in rat brain slices

Archives of Physiology and Biochemistry

Volumn 105, Issue 4, 1997, Pages 365-372

  Scuvee Moreau J ^a   Seutin, V ^a   Dresse, A ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

CA1 pyramidal cells; cholinergic agonists; cholinesterase inhibitors; hippocampus; intracellular recording; muscarinic antagonists

Indexed keywords

ACETYLCHOLINE; ATROPINE; MUSCARINE; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; PIRENZEPINE; TACRINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IN VITRO STUDY; MALE; NONHUMAN; PYRAMIDAL NERVE CELL; RAT;

ANIMALIA;

EID: 0030694611     PISSN: 13813455     EISSN: None     Source Type: Journal    
DOI: 10.1076/apab.105.4.365.9476     Document Type: Article

References (28)

1. BEN-ARI, Y., KRNJEVIC, K., REINHARDT, W. & ROPERT, N. (1981) Intracellular observations on the disinhibitory action of acetylcholine in the hippocampus. Neuroscience 6, 2475-2484.
2. BENARDO, L.S. & PRINCE D.A. (1982) Cholinergic pharmacology of mammalian hippocampal pyramidal cells. Neuroscience 7, 1703-1712.
3. COLE, A.E. & NICOLL, R.A. (1984a) The pharmacology of cholinergic excitatory responses in hippocampal pyramidal cells. Brain Res. 305, 283-290.
4. COLE, A.E. & NICOLL R.A. (1984b) Characterization of a slow cholinergic post-synaptic potential recorded in vitro from rat hippocampal pyramidal cells. J. Physiol. (London) 352, 173-188.
5. COLINO, A. & HALLIWELL J.V. (1993) Carbachol potentiates Q current and activates a calcium-dependent non-specific conductance in rat hippocampus in vitro. Eur. J. Neurosci. 5, 1198-1209.
6. DODD, J., DINGLEDINE, R. & KELLY, J.S. (1981) The excitatory action of acetylcholine on hippocampal neurones of the guinea pig and rat maintained in vitro. Brain Res. 207, 109-127.
7. DUTAR, P. & NICOLL, R.A. (1988) Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro. J. Neurosci. 8, 4214-4224.
8. DUTAR, P., BASSANT, M.H. & LAMOUR, Y. (1990) Effects of tetrahydro-9-aminoacridine on cortical and hippocampal neurons in the rat: an in vivo and in vitro study. Brain Res. 527, 32-40.
9. DUTAR, P., BASSANT, M.H., SENUT, M.C. & LAMOUR, Y. (1995) The septo-hippocampal pathway: structure and function of a central cholinergic system. Physiol. Rev. 75, 393-427.
10. EDWARDS, F.A. & KONNERTH, A. (1992) Patch-clamping cells in sliced tissue preparations. In: Methods in Enzymology, Vol. 207, Ion Channels. RUDY, B. & IVERSON, L.E. Eds. Academic Press. San Diego. pp. 208-222.
11. EHLERT, F.J., ROESKE, W.R. & YAMAMURA, H.I. (1995) Molecular biology, pharmacology, and brain distribution of subtypes of the muscarinic receptor. In: Psychopharmacology: The Fourth Generation of Progress. BLOOM, F.E. & KUPFER, D.J. Eds. Raven Press. New York, pp. 111-124.
12. HALLIWELL, J.V. & ADAMS, P.R. (1982) Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250, 71-92.
13. HARDY, J., ADOLFSSON, R., ALAFUZOFF, I., BUCHT, G., MARCUSSON, J., NYBERG, P., PERDAHL, E., WESTER, P. & WINBLAD, B. (1985) Transmitter deficits in Alzheimer's disease. Neurochem. Int. 7, 545-563.
14. HARRELL, L.E., CALLAWAY, R., MORERE, D. & FALGOUT, J. (1990) The effect of long-term physostigmine administration in Alzheimer's disease. Neurology 40, 1350-1354.
15. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPHREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995) International union of pharmacology committee on receptor nomenclature and drug classification. IX. Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 47, 255-266.
16. KNAPP, M.J., KNOPMAN, D.S., SOLOMON, P.R., PENDLEBURY, W.W., DAVIS, C.S. & GRACON, S.I. for the Tacrine Study Group (1994) A 30-week randomized controlled trial of high dose tacrine in patients with Alzheimer's disease. JAMA 271, 985-991.
17. LEFKOWITZ, R.J., HOFFMAN, B.B. & TAYLOR, P. (1990) Drugs acting at synaptic and neuroeffector junctional sites. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, eighth edition, Vol. I. GILMAN, A.G. et al. Eds. Pergamon Press. New York, pp. 84-121.
18. MADISON, D.V., LANCASTER, B. & NICOLL, R.A. (1987) Voltage clamp analysis of cholinergic action in the hippocampus. J. Neurosci. 7, 733-741.
19. NaKAJIMA, Y., NAKAJIMA, S., LEONARD, R.J. & YAMAGUCHI, K. (1986) Acetylcholine raises excitability by inhibiting the fast transient potassium current in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 83, 3022-3026.
20. NYAKAS, C., LUITEN, P.G.M., SPENCER, D.G. & TRABER, J. (1987) Detailed projection patterns of septal and diagonal band efferents to the hippocampus in the rat with emphasis on innervation of CA1 and dentate gyrus. Brain Res. Bull. 18, 533-545.
21. PARK, T.H., TACHIKI, K.H., SUMMERS, W.K., KLING, D., FITTEN, J., PERRYMAN, K., SPIDELL, K. & KLING, A.S. (1986) Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine. Anal. Biochem. 159, 358-362.
22. PEDDER, E.K., EVELEIGH, P., POYNER, D., HULME, E.C. & BIRDSALL, N.J.M. (1991) Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br. J. Pharmacol. 103, 1561-1567.
23. 3 muscarinic receptor depolarizes hippocampal pyramidal cells. Brain Res. 534, 257-262.
24. RICHELSON, E. (1995) Cholinergic transduction. in: Psychopharmacology: The Fourth Generation of Progress. BLOOM, F.E. & KUPFER, D.J. Eds. Raven Press. New York, pp. 125-134.
25. SCUVEE-MOREAU, J., SEUTIN, V. & DRESSE A. (1996) Effect of cholinomimetic drugs on hippocampal pyramidal cells recorded intracellularly in rat brain slices. Pflügers Arch.-Eur. J. Physiol. 431, R5.
26. SEGAL, M. (1982) Multiple actions of acetylcholine at a muscarinic receptor studied in the rat hippocampal slice. Brain Res. 246, 77-87.
27. SEGAL, M. (1988) Synaptic activation of a cholinergic receptor in rat hippocampus. Brain Res. 452, 79-86.
28. SRAMEK, J.J., HURLEY, D.J., WARDLE, T.S., SATTERWHITE, J.H., HOURANI, J., DIES, F. & CUTLER, N.R. (1995) The safety and tolerance of xanomeline tartrate in patients with Alzheimer's disease. J. Clin. Pharmacol. 35, 800-806.